| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $362.3M | — | +14.3% |
| Cost of Revenue | $118.5M | — | +23.3% |
| Gross Profit | $243.7M | — | +10.4% |
| R&D Expense | $58.7M | — | +55.0% |
| SG&A Expense | $143.6M | — | +7.4% |
| Operating Income | $41.5M | — | -14.7% |
| Pre-tax Income | $27.5M | — | +108.7% |
| Income Tax | $4.3M | — | -62.8% |
| Net Income | $22.3M | — | +106.8% |
| EPS (Basic) | $0.41 | — | +106.8% |
| EPS (Diluted) | $0.40 | — | +106.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $539.7M | -15.1% | -26.9% |
| Accounts Receivable | $229.3M | +6.2% | +13.5% |
| Inventory | $165.5M | +0.5% | +7.5% |
| Current Assets | $1.01B | -7.9% | -13.4% |
| Total Assets | $2.52B | -3.4% | -1.7% |
| Current Liabilities | $762.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $15.2M | — | -36.5% |
| Capital Expenditures | $14.3M | — | +32.4% |
| Investing Cash Flow | -$14.6M | — | -37.2% |
| Financing Cash Flow | -$94.2M | — | -2031.8% |
| Free Cash Flow | $926K | — | -93.0% |
| +2.8% |
| Long-term Debt | $285.3M | -24.1% | -54.6% |
| Total Liabilities | $1.31B | -7.2% | -14.4% |
| Stockholders' Equity | $1.21B | +0.9% | +17.1% |